Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • Cancer Prevention Pharmaceuticals amends IPO

    Cancer Prevention Pharmaceuticals Inc., Tucson, Ariz. Business: Cancer Date announced: 2016-05-19 Type: IPO To be raised: Up to $17.5 million Shares: 1.3 million Price: $12-$14 Underwriter: Aegis Capital Overallotment: …

    Published on 5/30/2016
  • Champions Oncology amends follow-on

    Champions Oncology Inc. (NASDAQ:CSBR), Hackensack, N.J. Business: Cancer Date announced: 2016-05-24 Type: Follow-on To be raised: Up to $5.8 million Shares: TBD Price prior: $4.05 Underwriter: National Securities Note: …

    Published on 5/30/2016
  • InspireMD amends private placement of convertible preferred stock and warrants

    InspireMD Inc. (NYSE-M:NSPR), Tel Aviv, Israel Business: Cardiovascular Date announced: 2016-05-19 Type: Private placement of convertible preferred stock and warrants To be raised: Up to $32.1 million Shares: 39,706 …

    Published on 5/30/2016
  • NantHealth amends IPO

    NantHealth LLC, Culver City, Calif. Business: Diagnostic, Bioinformatics Date announced: 2016-05-24 Type: IPO To be raised: Up to $100.8 million Shares: 6.5 million Price: $12.50-$15.50 Underwriters: Jefferies; Cowen; …

    Published on 5/30/2016
  • Aclaris completes private placement

    Aclaris Therapeutics Inc. (NASDAQ:ACRS), Malvern, Pa. Business: Dermatology Date completed: 2016-05-27 Type: Private placement Raised: $20 million Shares: 1.1 million Price: $18.50 Shares after offering: 21.4 million …

    Published on 5/30/2016
  • Advanced Proteome Therapeutics completes private placement of units

    Advanced Proteome Therapeutics Corp. (TSX-V:APC; FSE:0E8), Boston, Mass. Business: Drug delivery Date completed: 2016-05-19 Type: Private placement of units Raised: C$285,150 ($217,170) Units: 5.7 million Price: C$0.05…

    Published on 5/30/2016
  • Aldeyra Therapeutics completes follow-on

    Aldeyra Therapeutics Inc. (NASDAQ:ALDX), Burlington, Mass. Business: Autoimmune, Ophthalmic Date completed: 2016-05-26 Type: Follow-on Raised: $12 million Shares: 2.4 million Price: $5 Shares after offering: 12.1 …

    Published on 5/30/2016
  • Angle completes placing

    Angle plc (LSE:AGL), Guildford, U.K. Business: Supply/Service, Diagnostic Date completed: 2016-05-25 Type: Placing Raised: L10.2 million ($14.8 million) Shares: 15.8 million Price: 64.5p Shares after offering: 74.8 …

    Published on 5/30/2016
  • Appili Therapeutics completes venture financing

    Appili Therapeutics Inc., Halifax, Nova Scotia Business: Infectious Date completed: 2016-05-25 Type: Venture financing Raised: C$3.3 million ($2.5 million) Investors: Innovacorp; Government of Canada; private investors

    Published on 5/30/2016
  • Arrivo BioVentures completes venture financing

    Arrivo BioVentures LLC, Morrisville, N.C. Business: Neurology Date completed: 2016-05-25 Type: Venture financing Raised: $49 million Investors: Jazz Pharmaceuticals plc; Solas BioVentures; Rex Health Ventures; and other…

    Published on 5/30/2016
  • Cancer Genetics completes direct public offering

    Cancer Genetics Inc. (NASDAQ:CGIX), Rutherford, N.J. Business: Diagnostic, Cancer, Supply/Service Date completed: 2016-05-20 Type: Direct public offering Raised: $5 million Shares: 2.5 million Price: $2 Shares after …

    Published on 5/30/2016
  • Cel-Sci completes direct public offering

    Cel-Sci Corp. (NYSE-M:CVM), Vienna, Va. Business: Cancer, Infectious Date completed: 2016-05-24 Type: Direct public offering Raised: $5 million Shares: 10 million Price: $0.50 Shares after offering: 144.9 million …

    Published on 5/30/2016
  • Coherus BioSciences completes follow-on

    Coherus BioSciences Inc. (NASDAQ:CHRS), Redwood City, Calif. Business: Biosimilars Date completed: 2016-05-23 Type: Follow-on Raised: $63 million Shares: 3.5 million Price: $18 Shares after offering: 42.6 million …

    Published on 5/30/2016
  • DefiniGEN completes venture financing

    DefiniGEN Ltd., Cambridge, U.K. Business: Supply/Service Date completed: 2016-05-23 Type: Venture financing Raised: L1.5 million ($2.2 million) Investors: Cambridge Enterprise; 24Haymarket; Providence Investment; …

    Published on 5/30/2016
  • Great Basin completes private placement of units

    Great Basin Corp. (NASDAQ:GBSN), Salt Lake City, Utah Business: Diagnostic Date completed: 2016-05-26 Type: Private placement of units Raised: $6 million Units: 3.2 million Price: $1.90 (unit) Shares after offering: 7.1…

    Published on 5/30/2016
  • Intellipharmaceutics completes follow-on

    Intellipharmaceutics International Inc. (TSX:I; NASDAQ:IPCI), Toronto, Ontario Business: Drug delivery Date completed: 2016-05-27 Type: Follow-on Raised: $5.2 million Shares: 3.2 million Price: $1.61 (unit) Shares after…

    Published on 5/30/2016
  • Nucleix completes venture financing

    Nucleix Ltd., Rehovot, Israel Business: Diagnostic Date completed: 2016-05-23 Type: Venture financing Raised: $3 million Investors: Aurum Ventures; OrbiMed Advisors; private investor

    Published on 5/30/2016
  • OncoSec completes direct public offering

    OncoSec Medical Inc. (NASDAQ:ONCS), San Diego, Calif. Business: Cancer Date completed: 2016-05-26 Type: Direct public offering Raised: $10 million Shares: 665,049 Price: $1.82 Shares after offering: 17.6 million …

    Published on 5/30/2016
  • OvaScience completes follow-on

    OvaScience Inc. (NASDAQ:OVAS), Cambridge, Mass. Business: Endocrine/Metabolic, Genitourinary Date completed: 2016-05-26 Type: Follow-on Raised: $50.1 million Shares: 7.2 million Price: $7 Shares after offering: 34.5 …

    Published on 5/30/2016
  • Prometic completes follow-on

    ProMetic Life Sciences Inc. (TSX:PLI; OTCQX:PFSCF), Laval, Quebec Business: Cancer, Autoimmune, Dermatology Date completed: 2016-05-25 Type: Follow-on Raised: C$60.1 million ($45.8 million) Shares: 19.4 million Price: C…

    Published on 5/30/2016
  • Quest Diagnostics completes private placement of senior notes

    Quest Diagnostics Inc. (NYSE:DGX), Madison, N.J. Business: Diagnostic Date completed: 2016-05-26 Type: Private placement of senior notes Raised: $500 million Underwriters: Goldman Sachs; Mizuho; Wells Fargo; Credit …

    Published on 5/30/2016
  • Reata completes IPO

    Reata Pharmaceuticals Inc. (NASDAQ:RETA), Irving, Texas Business: Cancer, Neurology Date completed: 2016-05-26 Type: IPO Raised: $60.5 million Shares: 5.5 million Price: $11 Shares after offering: 21.5 million …

    Published on 5/30/2016
  • SymCel completes venture financing

    SymCel Sverige AB, Spanga, Sweden Business: Supply/Service Date completed: 2016-05-23 Type: Venture financing Raised: SEK5.6 million ($672,560) Investor: Company founders

    Published on 5/30/2016
  • Asterias financial update

    Asterias Biotherapeutics Inc. (NYSE-M:AST), Menlo Park, Calif. Business: Cancer, Neurology Date announced: 2016-05-23 Note: Asterias raised $2.5 million through the sale of 742,421 shares at $3.40 to cover the …

    Published on 5/30/2016
  • Atossa Genetics financial update

    Atossa Genetics Inc. (NASDAQ:ATOS), Seattle, Wash. Business: Cancer Date announced: 2016-05-27 Note: Atossa entered into a 30-month stock purchase agreement with Aspire Capital for up to $10 million.

    Published on 5/30/2016

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993